Development of RPA‐Cas12a ‐fluorescence assay for rapid and reliable detection of human bocavirus 1
Animal Models and Experimental Medicine · 2024
DOI: 10.1002/ame2.12298 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, 2024. Verfasst von Weidong Qian und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Food and Biological Engineering, Shaanxi University of Science and Technology, Xi'an, P. R. China. Hauptthemen laut MEDLINE: Human bocavirus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of China, Science and Technology Plan Project of Xi'an, Shenzhen Science and Technology Innovation Commission.
Abstract (Originalsprache)
Human bocavirus (HBoV) 1 is considered an important pathogen that mainly affects infants aged 6–24 months, but preventing viral transmission in resource‐limited regions through rapid and affordable on‐site diagnosis of individuals with early infection of HBoV1 remains somewhat challenging. Herein, we present a novel faster, lower cost, reliable method for the detection of HBoV1, which integrates a recombinase polymerase amplification (RPA) assay with the CRISPR/Cas12a system, designated the RPA‐Cas12a‐fluorescence assay. The RPA‐Cas12a‐fluorescence system can specifically detect target gene levels as low as 0.5 copies of HBoV1 plasmid DNA per microliter within 40 min at 37°C without the need for sophisticated instruments. The method also demonstrates excellent specificity without cross‐reactivity to non‐target pathogens. Furthermore, the method was appraised using 28 clinical samples, and displayed high accuracy with positive and negative predictive agreement of 90.9% and 100%, respectively. Therefore, our proposed rapid and sensitive HBoV1 detection method, the RPA‐Cas12a‐fluorescence assay, shows promising potential for early on‐site diagnosis of HBoV1 infection in the fields of public health and health care. The established RPA‐Cas12a‐fluorescence assay is rapid and reliable method for human bocavirus 1 detection. The RPA‐Cas12a‐fluorescence assay can be completed within 40 min with robust specificity and sensitivity of 0.5 copies/μl.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Food and Biological Engineering, Shaanxi University of Science and Technology, Xi'an, P. R. China.
- Department of Dermatology, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen, P. R. China.
- Ningbo Municipal Center for Disease Control and Prevention, Ningbo, P. R. China.
- Medical College of Shenzhen University, Shenzhen, P. R. China.
ORCID-Profile: Weidong Qian, Qian Zhang
Förderung
- Natural Science Foundation of China
- Science and Technology Plan Project of Xi'an
- Shenzhen Science and Technology Innovation Commission
- Medical Scientific Research Foundation of Guangdong Province
- Nanshan District Science and Technology Plan Project
- Scientific Research Program Funded by Shaanxi Provincial Education Department
- National Natural Science Foundation of China
- Science, Technology and Innovation Commission of Shenzhen Municipality
Zitieren
APA
Qian, W., Wang, X., Wang, T., Huang, J., Zhang, Q., Li, Y., & Chen, S. (2024). Development of RPA‐Cas12a ‐fluorescence assay for rapid and reliable detection of human bocavirus 1. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.12298
Vancouver
Qian W, Wang X, Wang T, Huang J, Zhang Q, Li Y, et al. Development of RPA‐Cas12a ‐fluorescence assay for rapid and reliable detection of human bocavirus 1. Animal Models and Experimental Medicine. 2024. doi:10.1002/ame2.12298
BibTeX
@article{Qian2024,
author = {Qian, Weidong and Wang, Xuefei and Wang, Ting and Huang, Jie and Zhang, Qian and Li, Yongdong and Chen, Si},
title = {Development of RPA‐Cas12a ‐fluorescence assay for rapid and reliable detection of human bocavirus 1},
journal = {Animal Models and Experimental Medicine},
year = {2024},
doi = {10.1002/ame2.12298}
}
EUVIMED